ADVANCING EXPOSOMICS RESEARCH

Significance of the Topic

Exposome research explores how lifelong environmental exposures shape biological processes and influence chronic disease risk. By leveraging advanced omics and bioinformatics, scientists can comprehensively profile chemical exposures in biological samples, complementing genomic data and uncovering key exposure–disease associations.

Study Aims and Overview

This article presents integrated workflows for exposomics and environmental health research. It outlines multi-omics strategies combining mass spectrometry, separation technologies, and bioinformatics to characterize internal chemical environments. Case–control and longitudinal cohort designs are highlighted for distinguishing exposure patterns between healthy and diseased populations.

Methodology and Instrumentation

Exposomic workflows employ high-resolution LC–Q-TOF and triple quadrupole MS systems. Key platforms include the Agilent 6550 Q-TOF with Jet Stream and ion-funnel technologies and the 6470 triple quadrupole with a 1290 Infinity II LC. Additional separation techniques encompass GC, SFC, and CE. Data acquisition and analysis are unified under MassHunter software alongside modules such as Spectrum Mill, METLIN, Profinder, VistaFlux, and Mass Profiler Professional.

Main Results and Discussion

Agilent platforms achieved femtogram-level sensitivity, sub-ppm mass accuracy, and broad dynamic range, enabling comprehensive annotation of blood metabolites. Exposome-wide association studies effectively differentiated chemical signatures linked to disease pathways. Integration of multi-omic datasets enhanced biomarker discovery and mechanistic understanding of exposure impacts.

Practical Benefits and Applications

The described workflows facilitate robust quantification of trace environmental toxins and endogenous metabolites. Applications span epidemiology, toxicology, and precision medicine. Unified instrumentation and software streamline laboratory operations, improve reproducibility, and accelerate research throughput in environmental health studies.

Future Trends and Applications

Emerging directions include integration of exposomics with artificial intelligence for predictive exposure modeling, real-time monitoring technologies, and expansion of comprehensive exposome databases. Advances in single-cell exposomics and high-throughput non-targeted screening will deepen insights into dynamic exposure–response relationships.

Conclusion

Integrated omics workflows and high-performance instrumentation empower exposome research by delivering detailed chemical profiling and advanced data analysis. These capabilities are essential for elucidating environmental contributions to human health and guiding preventative strategies.

References

• Wild C. Complementing the genome with an exposome: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1847–1850.
• Kingston HM, Rahman M. EPA Method 6800: Elemental and molecular speciated isotope dilution mass spectrometry. U.S. Government Printing Office; 2015.
• Fahrenholz T, Wolle MM, Kingston HM, Faber S, Kern JC 2nd, Pamuku M, Miller L, Chatragadda H, Kogelnick A. Molecular speciated isotope dilution mass spectrometric methods for accurate, reproducible and direct quantification of reduced, oxidized and total glutathione in biological samples. Anal Chem. 2015;87:1232–1240.
• Macherone A, Daniels S, Maggitti AL, Churley M, McMullin M, Smith MT. GC-MS/MS analysis of persistent organic pollutants in small volumes of human plasma. Agilent Technol Overview. 2016.
• Rappaport SM, Macherone A. Using the blood exposome to discover causes of disease. Agilent Technol Overview. 2013.
• Macherone A. Targeted exposomics: profiling urinary organic acids. Agilent App Note. 2013.
• Rappaport SM, Smith MT. Epidemiology: environment and disease risks. Science. 2010;330(6003):460–461.
• Smith MT, de la Rosa R, Daniels SI. Using exposomics to assess cumulative risks and promote health. Environ Mol Mutagen. 2015;56(9):715–723.
• Rappaport SM, Barupal D, Wishart D, Vineis P, Scalbert A. The blood exposome and its role in discovering causes of disease. Environ Health Perspect. 2014;122(8):769–774.
• Faber S, Zinn GM, Boggess A, Fahrenholz T, Kern JC 2nd, Kingston HM. A cleanroom sleeping environment’s impact on markers of oxidative stress, immune dysregulation and behavior in children with autism spectrum disorders. BMC Complement Altern Med. 2015;15:71.